Cyclo Therapeutics Inc. (CYTH)

NASDAQ: CYTH · Real-Time Price · USD

0.72

-0.00 (-0.08%)

At close: Mar 25, 2025, 3:59 PM

Cyclo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	9.25M	1.54M	16.61M	12.85M	2.78M	2.22M	1.27M	960.2K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	7.28K	49.81K	90.6K	259.74K	167.13K	203.03K
Other Long-Term Assets	n/a	-56.66K	n/a	n/a	n/a	-130.06K	n/a	n/a
Receivables	122.38K	54.99K	539.09K	111.79K	182.49K	117.48K	92.74K	124.06K
Inventory	254.35K	254.49K	227.44K	237.91K	242.63K	416.53K	471.22K	497.4K
Other Current Assets	n/a	2.31M	n/a	n/a	n/a	n/a	60.85K	53.88K
Total Current Assets	12.32M	4.16M	19.44M	14.05M	3.96M	2.77M	1.9M	1.64M
Property-Plant & Equipment	929.28K	56.66K	77.22K	87.92K	64.56K	18.57K	25.74K	29.98K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	929.28K	56.66K	84.5K	137.73K	155.16K	148.25K	192.86K	233.01K
Total Assets	13.25M	4.22M	19.52M	14.19M	4.11M	2.92M	2.09M	1.87M
Account Payables	4.86M	2.23M	3.68M	3.54M	3.12M	1.93M	943.03K	342.54K
Deferred Revenue	n/a	n/a	-3.68M	-3.54M	-3.12M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	133.71K	114.03K	16.39K	n/a	n/a	n/a
Other Current Liabilities	1.59M	902.61K	n/a	n/a	-16.39K	n/a	n/a	n/a
Total Current Liabilities	8.47M	3.48M	3.83M	3.67M	3.14M	1.93M	943.03K	342.54K
Long-Term Debt	n/a	n/a	18.03K	44.49K	36.13K	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	-36.13K	n/a	n/a	n/a
Total Long-Term Liabilities	22.48K	3.48M	18.03K	62.93K	36.13K	n/a	n/a	n/a
Total Liabilities	8.49M	3.48M	3.85M	3.74M	3.18M	1.93M	943.03K	342.54K
Total Debt	1.03M	n/a	170.99K	194.44K	52.51K	n/a	n/a	n/a
Common Stock	2.86K	849.00	841.00	477.00	12.15K	9.07K	7.3K	6.7K
Retained Earnings	-83.86M	-63.8M	-48.35M	-34.06M	-25.12M	-17.59M	-13.33M	-9.5M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	-130.06K	0.00	n/a
Shareholders Equity	4.76M	734.54K	15.67M	10.45M	935.98K	992.52K	1.15M	1.53M
Total Investments	n/a	n/a	7.28K	49.81K	90.6K	259.74K	167.13K	203.03K